Oxford Capital Partners and Imperial Innovations have co-led a £3.1m second round of funding for Veryan Medical Ltd, a developer of medical devices to improve the long-term effectiveness of medical care in patients with vascular disease. Existing investor NESTA also participated in the round. Nikko Principal Investments led the £2.6m series-A funding round in 2006. OCP and Imperial Innovations also participated in that deal.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020